Overview On this blog we have discussed the challenges of communicating medical affairs value a number of different times. Specifically, w...

We have been following the developments in the Amarin off-label communication case for awhile and you can find our posts that provide backg...

A couple of my clients have discussed the use of the Net Promoter Score lately so I thought I would address it in my blog. Quick backgro...

One of my readers asked me an interesting question: “Are there examples of successful MSL roles that are primarily office-based (minimal ...

A number of my friends in MA leadership have been debating the implications of the Amarin case for MA overall. Spoiler alert – I think ...

In a court case that may have huge implications for pharma, a federal district judge in Manhattan ruled that the FDA cannot prevent a c...